Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
albuterol (proventil) (1 trial)
budesonide (rhinocort) (1 trial)
ipratropium (atrovent) (1 trial)
mannitol (Osmitrol) (1 trial)
Lung Diseases (Phase 2)
Lung Diseases, Obstructive (Phase 2)
Trials (1 total)
Trial APIs (4 total)